NCT06572306Completed
Pharmacist-led Continuous Glucose Monitoring
Investigating the Impact of Pharmacist-led Flash Continuous Glucose Monitoring on Clinical and Behavioral Health Outcomes
Source: ClinicalTrials.gov · Last updated 15 Sept 2026
Brief summary (registry, in English)
This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 11 (actual)
- First submitted
- 23 Aug 2024
- Start date
- 1 Sept 2024
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- University of South Florida
- Diseases
- Type 2 diabetes
- NCT number
- NCT06572306
What you commit to
- Study type: Observational
- Participants enrolled: 11
- From 1 Sept 2024 to the primary completion date, 1 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- history of diabetic ketoacidosis or hyperosmolar hyperglycemic state within 6 months prior to study enrollment
Other illness
- history of hypoglycemia requiring third party assistance
- known allergy to medical grade adhesives
- current use of systemic steroids for any medical condition
Lab values
- any continuous glucose monitor use within 6 months prior to study enrollment
Other
- pregnant and planning to become pregnant during study time frame
- current use of dialysis
Who the study is looking for
- type 2 diabetes
- hemoglobin A1c ≥ 8%
- compatible smartphone with FreeStyle Libre 2 or Libre 3+ continuous glucose monitoring system
- current use and access to a glucometer for self-monitoring of blood glucose
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| USF Health Department of Family Medicine Coordinator of this site? Confirm its status | Tampa | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.